Guttate Psoriasis clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Guselkumab Immunogenetics

    open to eligible people ages 18 years and up

    This is a two-arm open-label study to evaluate the clinical and immunogenetic responses of patients with plaque or guttate psoriasis to treatment with guselkumab.

    at UCSF

Last updated: